Our Work
Latham & Watkins Advises Kfund on Investment in MiLaboratories
October 10, 2024
Emerging Companies & Growth team represented the venture capital firm in the computational biotech company’s US$10 million Series A funding round.
MiLaboratories, a leader in computational biology innovation, has announced the successful close of its Series A funding round, led by Kfund with additional backing from Speedinvest and other prominent investors. This funding milestone comes alongside the launch of its cutting-edge Platforma.bio Software Development Kit, a revolutionary tool that streamlines and transforms how biologists build and deliver analytics and insights from next-generation sequencing data.
Latham & Watkins LLP represented Kfund in the transaction with an Emerging Companies & Growth team led by New York partner Peyton Worley, with associate Saem Kim.